Adaptimmune Therapeutics PLC (ADAPY) Liabilities and Shareholders Equity (2015 - 2025)
Adaptimmune Therapeutics (ADAPY) recorded Liabilities and Shareholders Equity of $130.63 million in Q2 2025, down 59.4% from $321.7 million a year earlier and down 17.4% from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Liabilities and Shareholders Equity (2015 - 2025) Analysis & Trends
At the end of FY2024, Adaptimmune Therapeutics reported Liabilities and Shareholders Equity of $245.96 million, down 13.0% from FY2023.
- Annual Liabilities and Shareholders Equity has declined for three straight years, though with a five-year compound annual growth rate of 6.3% (FY2019 to FY2024).
- Across earlier years, Liabilities and Shareholders Equity came in at $282.62 million in FY2023 (-14.1%), $328.92 million in FY2022 (-30.0%), $469.55 million in FY2021 (+4.1%) and $451.14 million in FY2020 (+148.5%).
- The Q2 2025 figure is the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2015.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined for three consecutive quarters, with an average decline of 18.2% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 148.5% in Q4 2020, against a decline of 59.4% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $158.07 million (Q1 2025), $245.96 million (Q4 2024) and $317.44 million (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 130.63 Mn |
| Mar 31, 2025 | 158.07 Mn |
| Dec 31, 2024 | 245.96 Mn |
| Sep 30, 2024 | 317.44 Mn |
| Jun 30, 2024 | 321.70 Mn |
| Mar 31, 2024 | 258.01 Mn |
| Dec 31, 2023 | 282.62 Mn |
| Sep 30, 2023 | 296.64 Mn |
| Jun 30, 2023 | 342.98 Mn |
| Mar 31, 2023 | 288.08 Mn |
| Dec 31, 2022 | 328.92 Mn |
| Sep 30, 2022 | 332.20 Mn |
| Jun 30, 2022 | 388.27 Mn |
| Mar 31, 2022 | 419.80 Mn |
| Dec 31, 2021 | 469.55 Mn |
| Sep 30, 2021 | 353.53 Mn |
| Jun 30, 2021 | 389.79 Mn |
| Mar 31, 2021 | 411.58 Mn |
| Dec 31, 2020 | 451.14 Mn |
| Sep 30, 2020 | 479.02 Mn |
API Access
Adaptimmune Therapeutics PLC Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();